MedlinePlus Health Information: A service of the National Library of Medicine and the National Institutes of Health

Alpha-1 Antitrypsin Deficiency

URL of this page: http://www.nlm.nih.gov/medlineplus/alpha1antitrypsindeficiency.html

Also called: Also called: AATD, Alpha-1, Inherited emphysema

Alpha-1 antitrypsin deficiency is an inherited disorder that can cause lung disease in adults and liver disease in adults and children. Alpha-1 antitrypsin (AAT) is a protein that protects the lungs. The liver usually makes the protein, and releases it into the bloodstream. Because of a gene problem, some people have little or none of it. Not having enough AAT puts you at risk of emphysema or liver problems. Three in four adults with a severe deficiency will get emphysema, some when they are younger than 40. If you smoke, you increase your risk. Children with AAT deficiency can develop liver problems that last their whole lives.

AAT deficiency can be treated but not cured. One treatment involves adding to or replacing the missing protein. A lung transplant may be an option if you are seriously ill. Staying away from cigarette smoke is crucial.

A blood test can tell if you have the deficiency. If you have it, your family members should also take the blood test.

Start Here Overviews Diagnosis/Symptoms Disease Management Related Issues Clinical Trials Genetics Journal Articles
References and abstracts from MEDLINE/PubMed (National Library of Medicine)
Directories Organizations You may also be interested in these MedlinePlus related pages:

The primary NIH organization for research on Alpha-1 Antitrypsin Deficiency is the National Heart, Lung, and Blood Institute - http://www.nhlbi.nih.gov/

Date last updated: October 15 2008
Topic last reviewed: August 25 2008